Target therapy of cancer: implementation of monoclonal antibodies and nanobodies
{{output}}
In the past decades, the mainstay of systemic therapy for solid and haematological malignancies was chemotherapy; nevertheless this modality has the drawbacks such as drug resistance and eliciting sever cytotoxicity in the normal tissue. To resolve such downsi... ...
